Viewing StudyNCT00123929



Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00123929
Status: COMPLETED
Last Update Posted: 2009-08-06
First Post: 2005-07-22

Brief Title: Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer
Sponsor: Hospital San Carlos Madrid
Organization: Hospital San Carlos Madrid

Organization Data

Organization: Hospital San Carlos Madrid
Class: OTHER
Study ID: 05117
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Hospital San Carlos Madrid
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Miguel Martin MD
Old Organization: Hospital San Carlos

Collaborators

Name Class
UNC Lineberger Comprehensive Cancer Center OTHER